4th Quarter - Report

PARRY, ROMANI, DECONCINI & SYMMS for PLASMA PROTEIN THERAPEUTICS ASSOCIATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitor S. 1695, Biologics Price Competition and Innovation Act of 2007, to ensure that it does not apply to plasma proteins. S. 1376 and H.R. 2606, 340B Program Improvement and Integrity Act of 2007; H.R. 2860 - Health Care Access and Rural Equity (H-CARE) Act of 2007: Ensure bills do not expand this program at the expense of patient access to plasma protein therapies. Monitor H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008. Maintain status quo for the Medicaid rebate as applied to plasma protein therapies.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
DENNIS DECONCINI —
JAMES ROCK —
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1376 (110th), S. 1695 (110th), H.R. 6331 (110th), H.R. 2606 (110th), H.R. 2860 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.